Clinical Guides
Long QT Syndrome
A clinically focused clinical guide to recognizing congenital and acquired long QT syndrome, measuring QT accurately, preventing torsades de pointes, and organizing specialist and family care in India.
MedNext Academy | 15 min read
Long QT Syndrome
A clinically focused clinical guide to recognizing congenital and acquired long QT syndrome, measuring QT accurately, preventing torsades de pointes, and organizing specialist and family care in India.
Summary
Long QT syndrome (LQTS) is a disorder of ventricular repolarisation that creates susceptibility to torsades de pointes, ventricular fibrillation, syncope and sudden cardiac death. Congenital LQTS usually reflects a pathogenic ion-channel variant, whereas acquired QT prolongation is commonly driven by medicines, electrolyte disturbance, bradycardia or acute illness. The categories overlap: an apparently drug-induced episode may expose reduced repolarisation reserve in a genetically susceptible person. A normal single electrocardiogram (ECG) does not exclude congenital disease, and an automated prolonged QT value does not establish it.
The practical sequence is to confirm the tracing, measure the QT manually, calculate and document QTc, identify reversible causes, reconstruct the event and family history, and obtain inherited-arrhythmia advice when suspicion persists. Syncope during exertion, swimming, sudden auditory stimulation or intense emotion; unexplained seizure-like collapse; congenital deafness; and premature sudden death in relatives are important clues. Risk is not represented by QTc alone. Age, sex, genotype, previous cardiac arrest, arrhythmic syncope, treatment adherence, exposure to QT-prolonging drugs and electrolyte loss all modify it.
Acute polymorphic ventricular tachycardia with instability is an emergency requiring resuscitation and correction of precipitating factors under a monitored protocol. Long-term care may include a non-selective beta-blocker, genotype-informed advice, left cardiac sympathetic denervation or an implantable cardioverter-defibrillator (ICD) in selected high-risk patients. Every suspected inherited case needs a family plan. This draft is educational, has been reviewed by the MedNext Clinical Team and does not replace electrophysiology, genetics, emergency or local formulary guidance.
How Common Is It?
Congenital LQTS is uncommon but clinically important because the first recognized event can be cardiac arrest. GeneReviews cites an estimated prevalence around 1 in 2,500, based largely on non-Indian populations and ascertainment methods that do not capture every genotype-positive person with a normal resting QTc. That figure should be treated as an orientation, not an Indian prevalence estimate. India does not have a complete population registry that can reliably state how many people have genetically confirmed LQTS, how many remain undiagnosed or how access differs between states.
Measured frequency changes with the denominator. A paediatric inherited-arrhythmia clinic, a family-screening cohort, an emergency cohort with syncope and a community ECG survey answer different questions. Genetic yield also depends on phenotype strength, gene panel design, variant classification and laboratory practice. A negative panel does not exclude a clinically compelling diagnosis, while a variant of uncertain significance must not be counted as a confirmed case. Acquired QT prolongation is more common than congenital LQTS, especially during polypharmacy, acute illness, renal or hepatic dysfunction, electrolyte depletion and bradycardia, but the frequency depends strongly on the setting and the threshold used.
Under-recognition can arise when abrupt arrhythmic syncope is labelled vasovagal or epileptic, when QT is accepted from the ECG machine without checking, or when a relative's sudden death is recorded without a cardiovascular review. Overdiagnosis can arise from measuring through a U wave, using an inappropriate correction at an extreme heart rate, or interpreting a transient reversible prolongation as inherited disease. Good epidemiology therefore begins with reproducible measurement and explicit case definitions rather than a large unsupported national claim.
Risk Factors
Risk of congenital LQTS begins with the electrical phenotype and genotype but is shaped by clinical exposure. A previous resuscitated cardiac arrest is a major marker of future danger. Arrhythmic syncope, very prolonged QTc, events despite correctly taken therapy, infancy or childhood presentation, and certain genotypes or variant locations may increase concern. Triggers can be genotype-associated rather than absolute: exertion and swimming are classically important in KCNQ1-related disease, sudden sounds or emotional arousal in KCNH2-related disease, and rest or sleep in SCN5A gain-of-function disease. These patterns support interpretation but cannot diagnose a genotype or justify deliberately provoking an event.
Acquired risk accumulates through multiple hits. Review every prescription, over-the-counter product, antimicrobial, antiemetic, psychotropic, opioid, antihistamine and supplement against a current QT-risk resource. The CredibleMeds list is dynamic; copying a fixed list into a note is unsafe because categories change. Hypokalaemia, hypomagnesaemia, hypocalcaemia, starvation, repeated vomiting, diarrhoea, diuretic exposure, renal or hepatic impairment, bradycardia, recent conversion from atrial fibrillation and interacting drugs can magnify torsades risk. Women generally have longer post-pubertal QTc and greater drug-related susceptibility, while pregnancy and particularly the postpartum period require individualized inherited-arrhythmia review.
Family history should cover three generations: sudden unexplained death, drowning, single-vehicle crash, nocturnal death, sudden infant death, unexplained seizure, congenital deafness, ICD implantation and known channelopathy. Absence of a reported history is not protective because penetrance is incomplete, families are small and diagnoses may have been missed. Conversely, a relative's sudden death is not, by itself, an ICD indication for an asymptomatic person.
Diagnosis
History
Reconstruct every collapse: posture, exertion, swimming, emotion, alarm or telephone sound, prodrome, palpitations, duration, colour, breathing, injury, witnessed movements and recovery. Arrhythmic syncope is often abrupt with rapid recovery, but convulsive movements can occur during cerebral hypoperfusion. Ask about medicines started or increased, vomiting, diarrhoea, dieting, fever, kidney or liver disease, hearing loss and previous ECGs. Obtain a three-generation pedigree and, where lawful and available, records from unexplained deaths.
Examination
Start with physiological stability and a cardiovascular and neurological examination. Record heart rate, rhythm, blood pressure, perfusion and features of structural heart disease or syndromic disease. Congenital LQTS often has no abnormal physical sign. Examine for dehydration and causes of electrolyte loss. In a collapse, assess injury, glucose and neurological recovery while maintaining rhythm monitoring. Congenital deafness raises the possibility of Jervell and Lange-Nielsen syndrome, but normal hearing does not reduce ordinary autosomal-dominant LQTS risk.
Investigations
Inspect the 12-lead ECG rather than accepting the printed QTc. Use a clear lead, commonly II or V5/V6; measure from earliest QRS onset to the end of the T wave using a tangent or threshold method, exclude a distinct U wave, average representative beats and document QT, RR, lead and correction formula. Bazett QTc equals QT divided by the square root of RR; it tends to overcorrect in tachycardia and undercorrect in bradycardia, so calculate Fridericia QTc when rate is far from normal and seek specialist interpretation. Wide QRS complexes require adjusted/JT assessment. Repeat ECGs after correcting reversible factors. Check potassium, magnesium, calcium, renal function and relevant drug concentrations. Exercise recovery ECG, ambulatory monitoring and genetic testing are specialist tools; an epinephrine challenge is not a routine primary-care test.
Differential Diagnosis
The first distinction is congenital LQTS versus secondary QT prolongation. A medication can directly delay repolarisation, inhibit metabolism of another drug or create hypokalaemia through vomiting or diuresis. Electrolyte depletion, severe bradycardia, hypothermia, myocardial ischaemia, intracranial catastrophe, starvation and endocrine or systemic illness can lengthen QT. Repeat measurement after correction is essential, but normalization does not automatically erase inherited susceptibility when the phenotype, event or pedigree is compelling.
Not every apparent long QT is real. Automated algorithms may include a U wave, choose a noisy lead or misidentify T-wave termination. Bundle-branch block, ventricular pacing and pre-excitation widen depolarisation and make ordinary QTc thresholds misleading. Bazett correction can exaggerate QTc during tachycardia. Compare several leads and prior tracings and request cardiology interpretation rather than diagnosing from one machine value. Early repolarisation, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome and accessory-pathway arrhythmia can cause syncope or sudden death without the same repolarisation pattern.
The collapse differential remains broad. Vasovagal syncope usually has a recognizable prodrome and trigger, orthostatic hypotension relates to standing or volume loss, and structural obstruction may produce exertional symptoms. Epileptic seizure can produce lateral tongue biting and a prolonged postictal state, but brief jerks do not prove epilepsy. Hypoglycaemia, pulmonary embolism, haemorrhage and intoxication must be considered according to context. Family-wide evaluation also distinguishes a true pathogenic variant from a variant of uncertain significance. A VUS is not a positive diagnostic result and should not be used for predictive cascade testing or irreversible device decisions.
Management
Management has three continuous aims: prevent triggers, suppress malignant ventricular arrhythmia and identify relatives who need protection. Correct hypokalaemia, hypomagnesaemia and other reversible factors; stop or substitute a culprit medicine only through a safe clinical plan; and check the current QT-risk database before any new prescription. Give the patient a written medicines and illness plan that addresses vomiting, diarrhoea, fasting and missed doses. Advise emergency assessment after exertional or abrupt unexplained syncope, sustained palpitations or seizure-like collapse.
For congenital LQTS, a long-acting non-selective beta-blocker such as nadolol or propranolol is commonly preferred under inherited-arrhythmia supervision. Choice and dose depend on age, weight, genotype, exercise heart-rate response, comorbidity, pregnancy status, availability and adherence. Treatment failure should not be declared until adherence, dose adequacy and prohibited drug exposure have been checked. Selected SCN5A-related disease may receive specialist sodium-channel therapy, but this is not an empirical primary-care intervention.
Left cardiac sympathetic denervation can reduce events when beta-blockers are ineffective, not tolerated or insufficient and may be considered alongside device strategy at an experienced centre. An ICD is indicated after cardiac arrest in many survivors and may be appropriate for recurrent arrhythmic syncope or very high risk despite therapy, but it creates risks of inappropriate shocks, lead failure, infection and repeated procedures, especially in young people. It does not replace medicine or trigger avoidance. Exercise advice is individualized by an inherited-arrhythmia specialist; blanket inactivity is harmful, while unsupervised high-intensity or aquatic activity can be unsafe in selected genotypes. Family emergency planning should include cardiopulmonary resuscitation awareness and access to an automated external defibrillator where feasible.
Prescribing Information
Beta-blocker prescribing for congenital LQTS is specialist-led. Nadolol and propranolol have the strongest accumulated disease-specific experience; short-acting metoprolol should not be assumed equivalent simply because it belongs to the same class. Record the exact product, formulation, dose, timing and weight-based review plan. Monitor resting and exercise heart rate, blood pressure, symptoms, adherence and adverse effects. Asthma, bradycardia, conduction disease, diabetes, depression, pregnancy and breastfeeding require individualized assessment. Abrupt withdrawal can remove protection and should be avoided unless an emergency clinician directs otherwise.
Medication reconciliation must use a live QT-risk source. CredibleMeds separates known, possible and conditional torsades risk and maintains a specific drugs-to-avoid resource for congenital LQTS; its list changes and must be checked at the time of prescribing. Do not reproduce a frozen list. When a QT-risk drug is essential, document why alternatives are unsuitable, baseline QT/QTc and electrolytes, interacting drugs, renal and hepatic function, planned monitoring and the threshold for stopping or escalation. Avoid combining QT-prolonging drugs without explicit risk review. Replace potassium or magnesium according to measured deficit, renal function and monitored local protocol rather than an internet dose.
Acute torsades management occurs in a monitored resuscitation setting. Defibrillate pulseless or unstable rhythms according to life-support protocols, withdraw precipitating agents, correct electrolytes and address bradycardia; intravenous magnesium and pacing or isoprenaline for selected acquired pause-dependent torsades require senior protocol-based use. Isoprenaline can be inappropriate in congenital LQTS. Mexiletine and other genotype-directed agents require electrophysiology oversight. Every discharge prescription should be reconciled with the current list, supplied for continuity and communicated to primary care, dentistry, psychiatry, emergency services and pharmacy.
When to Refer
Arrange urgent cardiology or inherited-arrhythmia assessment after resuscitated cardiac arrest, documented torsades, exertional or emotion-triggered syncope, recurrent unexplained seizure-like episodes, a persistently prolonged manually confirmed QTc without a reversible cause, or a concerning family history. A QTc around or above 480 ms on repeated ECGs in the absence of secondary causes contributes strongly to clinical diagnosis, but borderline results with a persuasive history also deserve review. Do not delay referral until genetic testing is locally arranged; the phenotype must be assessed first.
The referral should include original ECG files rather than only machine reports, manual QT and RR measurements, correction formula, serial electrolytes, complete medicines and supplement list, event description, witness account, exercise relation, hearing history, prior ECGs and a three-generation pedigree. State which suspected QT-prolonging drugs have been stopped and what clinically necessary treatments remain. Children, pregnancy, postpartum presentation and families with multiple deaths need age-appropriate specialist coordination.
Genetic counselling should precede or accompany testing. A focused panel of genes with definitive disease association is preferable to indiscriminate testing that increases uncertain results. If a pathogenic or likely pathogenic variant explains the phenotype, offer targeted cascade testing to first-degree relatives with counselling. If no familial variant is found, first-degree relatives may still require ECG and clinical assessment because a negative panel does not exclude disease. Device or denervation decisions, recurrent symptoms despite therapy and competitive-sport questions should be referred to an experienced inherited-arrhythmia centre. In India, establish the feasible pathway and costs before promising testing or intervention, and give families a plan that remains safe if tertiary review is delayed.
Red Flags
Cardiac arrest, sustained polymorphic ventricular tachycardia, haemodynamic instability or recurrent syncope with ventricular ectopy requires immediate resuscitation-level care. Place defibrillation pads, obtain continuous monitoring, correct hypoxia and measured electrolyte abnormalities, stop avoidable QT-prolonging agents and involve senior cardiology or critical care. Do not allow a stable interval between episodes to create false reassurance: torsades can terminate spontaneously and recur. A patient with prolonged QT plus frequent premature beats, couplets, pauses or alternating T-wave amplitude needs urgent monitored review.
Syncope during exercise or swimming, after sudden auditory stimulation, without a typical vasovagal prodrome, or with a family history of premature sudden death is high risk. Seizure-like movement followed by rapid recovery may be arrhythmic; a previous epilepsy label does not close the differential. New QT prolongation during sepsis, starvation, diarrhoea, repeated vomiting, renal failure, overdose or interacting medicines can deteriorate quickly. Severe hypokalaemia or hypomagnesaemia, marked bradycardia and a rapidly increasing QTc magnify danger.
For a known LQTS patient, red flags include collapse despite prescribed beta-blocker, missed medication during intercurrent illness, an unavoidable QT-risk drug without monitoring, ICD shock, wound redness or fever after implantation, repeated inappropriate shocks, and syncope during pregnancy or postpartum. A relative's sudden unexpected death should trigger urgent re-evaluation of the family plan rather than automatic device implantation. Do not recommend that a patient test exercise tolerance alone, stop a beta-blocker abruptly or rely on a wearable rhythm notification to exclude torsades. The emergency handover must name the diagnosis or suspicion, current drugs, last doses, electrolytes, device status and specialist contact.
Indian Clinical Context
Access to inherited-arrhythmia clinics, clinical genetics, validated multigene panels, exercise testing, left cardiac sympathetic denervation and paediatric or adult device expertise varies substantially across India. A commercial panel is not equivalent to a complete diagnostic service. Before testing, confirm laboratory accreditation, gene content, variant classification method, access to pre- and post-test counselling, whether segregation testing is offered, turnaround time, cost and who will reinterpret variants as knowledge changes. A negative report does not end phenotypic follow-up, and a VUS should not be sold to a family as the cause.
Medicine availability also varies. If the preferred beta-blocker is difficult to source, the inherited-arrhythmia clinician should choose and document the safest feasible alternative rather than allowing repeated unsupervised switching. Prescribers should check Indian brand composition, combination products, renal and hepatic function and a live QT-risk source. Antibiotics, antiemetics and psychotropics are common points of accidental exposure across fragmented care; a wallet card or phone record in the patient's language can help, but it does not replace pharmacist and clinician review.
ICD implantation requires more than a device purchase. Families need counselling about generator replacement, lead surveillance, wound and infection care, remote or in-person checks, inappropriate shocks, sports and occupational implications, and reliable access after a shock. Referral may require travel; the local team should plan interim drug supply, electrolyte checks and emergency contacts. Family screening should begin with first-degree relatives and can use staged ECG/clinical evaluation while genetic access is arranged. Emergency care follows the nearest capable service, not a distant ideal pathway. Do not imply that Ayushman Bharat, private insurance or a state scheme will cover a specific genetic test, operation or device until eligibility and package details are confirmed for that patient.
NMC Competency Mapping
The NMC CBME Curriculum 2024 provides core foundations rather than a stand-alone undergraduate LQTS competency. PY5.5 covers the physiology, axis and applications of the ECG. PY5.6 requires discussion of physiological variation, abnormal waveforms and intervals, arrhythmias and heart block. PH4.10 covers the pharmacokinetics, pharmacodynamics, therapeutic uses and adverse reactions of drugs used for arrhythmias, together with planning management of supraventricular and ventricular arrhythmias, cardiac arrest and fibrillation. These competencies support QT measurement, recognition of polymorphic ventricular tachycardia and medication safety.
At Know and Know How levels, a learner should explain ventricular depolarisation and repolarisation, distinguish QT from QTc, state the limitations of Bazett correction and identify common reversible causes. The learner should recognize that a distinct U wave is not included, an automated QTc must be verified and a wide QRS changes interpretation. Pharmacology integration should emphasize drug interactions, electrolyte-mediated risk and the need for a current source rather than memorizing a static list.
At Show How level, a learner can demonstrate manual measurement on a supplied ECG, calculate Bazett and Fridericia QTc from given QT and RR intervals, take an event and three-generation family history, reconcile medicines and deliver a structured urgent handover. Undergraduate competence does not include independently diagnosing a pathogenic variant, prescribing genotype-specific treatment, clearing competitive sport or selecting an ICD. Assessment should reward recognition of uncertainty and escalation. An OSCE station should provide a de-identified tracing and explicit measurements rather than asking the learner to infer a barely visible T-wave endpoint from a poor reproduction.
Key Exam Pearls for NEET PG
The QT interval runs from the earliest QRS onset to the end of the T wave and represents ventricular depolarisation plus repolarisation. Do not include a separate U wave. QT varies with heart rate, so report a corrected value and the formula. Bazett uses QT divided by the square root of RR and overcorrects at fast rates while undercorrecting at slow rates; Fridericia uses the cube root of RR. Always check machine measurements manually in a clear lead. Repeated QTc prolongation without a secondary cause, a compatible event history and a pathogenic variant are complementary diagnostic evidence.
Torsades de pointes is a polymorphic ventricular tachycardia associated with prolonged repolarisation and changing QRS axis around the baseline. It may cause abrupt syncope, seizure-like activity or cardiac arrest. Acquired causes include QT-prolonging drugs, hypokalaemia, hypomagnesaemia, hypocalcaemia and bradycardia. Remove precipitants and treat an unstable rhythm through resuscitation protocols. Congenital trigger associations are KCNQ1 with exertion or swimming, KCNH2 with sudden sound or emotion, and SCN5A gain-of-function with rest or sleep; associations are not diagnostic.
Non-selective beta-blockers are the main preventive medicine for many patients with congenital LQTS. An ICD is secondary prevention after cardiac arrest and selected primary prevention after specialist risk assessment, not a reflex response to one borderline QTc or family anxiety. Left cardiac sympathetic denervation is an option for selected patients with inadequate control or intolerance. Genetic testing should focus on validated disease genes and be paired with counselling; cascade test relatives for a causative pathogenic or likely pathogenic variant, not a VUS. Continue phenotypic screening when the family is compelling but the panel is negative.
Frequently Asked Questions
Does one automated ECG report showing a long QT diagnose congenital long QT syndrome?
No. The tracing must be checked for artefact, rhythm, QRS width and a clearly defined T-wave end, then QT and RR should be measured manually and corrected with a documented formula. Medicines, electrolytes, acute illness and bradycardia must be assessed. Repeated ECGs, event and family history, exercise recovery findings and appropriately interpreted genetic testing may all contribute to diagnosis. A high-risk collapse still warrants urgent specialist review even when a repeat QTc is borderline.
Where should clinicians check whether a medicine is unsafe in long QT syndrome?
Use a current, maintained QT-risk resource such as CredibleMeds at the time of prescribing, alongside the product information, interaction checker and local formulary. Do not rely on a screenshot or printed list because classifications change. Review prescription, over-the-counter and complementary products, renal and hepatic function, electrolytes and interacting medicines. A patient should not abruptly stop an essential medicine without clinical advice; the prescriber should document the alternative or monitoring plan.
Should all relatives of a person with long QT syndrome have genetic testing?
Start with genetic counselling and careful evaluation of the affected index person. When a pathogenic or likely pathogenic variant explains the phenotype, targeted cascade testing can be offered to first-degree relatives and extended through the pedigree as results indicate. A variant of uncertain significance should not be used as a predictive family test. If no causative variant is found, first-degree relatives may still need clinical review and ECG assessment because current panels do not detect every cause.
Can a person with long QT syndrome exercise or play sport?
Many people can remain physically active, but advice is individualized. The specialist considers genotype, QTc, previous events, treatment adherence, device status, the proposed activity and rescue arrangements. Swimming and intense exertion can be important triggers in some genotypes, so unsupervised blanket clearance is unsafe; equally, universal inactivity has physical and psychological harms. Shared decision-making should produce a written plan for medication, hydration, supervision, emergency response and any activity-specific restrictions.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic